Seeking Alpha

GERN
  Geron Corporation - NASDAQ

11/27/2014, 9:36 AM ET
  • John Motyka | Send Message 3 Oct 2012

    756; GERN has one uniquely special product left to trial out. Do or die time...jdm
    Reply
      GERN vs. ETF Alternatives
      Company Description
      Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States